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Nowadays, 85% of infants with congenital heart defects (CHD)
reach adulthood and this adult population is expanding rapidly [1–4].
Advances in cardiac surgery made operative repair of CHD possible.
However, complete cure is seldom achieved. In most repaired defects
late complications and residual lesions occur frequently. The mis-
perception of “cure” has potentially serious consequences as patients
do not seek continued medical advice and are lost to follow-up [5].
Furthermore, young adolescents growing-upwith CHDmight struggle
with psychosocial concerns because a complete recovery is impos-
sible. These patients strive to lead a “normal” life [6]. As a consequence
patients deny their chronic disease and do not seek medical care.
Probably a large proportion of adults with CHD fails to receive regular
cardiac care and is lost to follow-up. A recent study reported that 61%
of adult patients with congenital heart disease (CHD) fail to receive
cardiac follow-up in Canada [7]. In the Netherlands, we estimated that
one third (approximately 8000) of adults with CHD are lost to follow-
up (see method section) [8]. Although the estimated number of
patients who fail to receive follow-up is lower in the Netherlands, we
still believe it is unacceptably high. To increase awareness of adult
patients with CHD and to identify patients who are lost to follow-up,
the CONCOR projectgroup [9] initiated a nationwide media campaign
entitled, "Wanted! 8000 Heart Patients”.
In January 2009, we started a national campaign to identify adult
patients with CHD lost to follow-up. The campaign consisted of a
nationwide call via billboards and advertisements. In total approxi-
mately 1200 billboards were placed in 24 cities nationwide for a
period of 1 to 2 weeks from January 2009 to May 2009. Adults with
CHD between 20 and 40 years old, whowere lost to cardiac follow-up,
were incited to call the CONCOR project group. This age-group was
speciﬁcally mentioned to avoid confusion with acquired cardiac
lesions.
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During the campaign and thereafter, adults with CHDwere able to call
the CONCOR project group or could register themselves via a website,
speciﬁcally designed for this campaign (www.8000vermisten.nl.) Three
research nurses specialized into CHD, handled incoming patient calls and
emails. After registration, patients were sent a CONCOR patient registra-
tion form and were advised to contact their general practitioner and to
make an appointment with a cardiologist. After one year, patients were
contacted again to collect information about the follow-up after
registration. Data on how many patients were seen by their cardiologist
and the clinical consequences and events were assessed.
From January 2009 till January 2010, 1261 patients have contacted
the CONCORproject group by telephone and email. In total, 593 patients
(65% female, mean age 40±12 years) were included. Table 1 shows all
included CHD, of which 1.0% was severe CHD. After 1 year, 80% of the
patients have been called again by a research nurse. In total, 66% of
patients had contacted their cardiologist. Twenty-two percent required
cardiac follow-up within 1 year. In 53 patients (16%) cardiac examina-
tion resulted in 76 new ﬁndings: 20% related to the aortic valve and
aorta, 14% to the pulmonary valve, 10% to the mitral valve, 18% were
arrhythmias or other electrical conduction abnormalities and a hetero-
geneous group (33%) of other symptoms (e.g. systemic hypertension,
heart failure, tricuspid valve regurgitation). Most ﬁndings were mild,
although 3 patients with repaired tetralogy of Fallot even needed
pulmonary valve replacement shortly after registration.
Our campaign has led to the identiﬁcation of 593 lost patients with
CHD. To our knowledge, this is the ﬁrst time that data of a
comprehensive national campaign on this actual topic has been
published. Interestingly, not only patients with minor CHD were
identiﬁed, but also patients with severe CHD were found (double
chambered right ventricle and transposition of the great arteries). A
substantial number of unknown residual lesions have been identiﬁed
and a minority needed prompt intervention. According to current
guidelines these patients with severe CHD need regular cardiac
follow-up, as we know that long-term morbidity is high [10]. Patients
with prior cardiac surgery often consider themselves “cured,”
although the majority faces a lifetime of problems including
arrhythmias,heart failure, hypertension, vascular complications and
one or more re-operations. Even patients with repaired “simple”
lesions such as an atrial septal defect may not have normal survival if
they are repaired in adulthood. Despite successful surgery for aortic
coarctation, the prevalence of hypertension in adults 10 to 20 years
after repair is 20% to 40% [11] and they may have premature
cardiovascular complications [5,12,13]. Besides registration we
advised patients to contact their general practitioner and we
encouraged to visit a cardiologist. In 16% of patients, unknown
residual lesions were found of whom 6% needed an operation.
Extrapolation to the total group of patients lost to follow-up would
indicate that a substantial number of patients have unknown residual
lesions. A minority of these patients needs a prompt intervention.
Thirty-four percent of patients did not visit a cardiologist due to
various reasons. A remarkable and common ﬁnding was that the
general physician disagreed with the need to visit a cardiologist. This
indicates that awareness among general practitioners on this topic is
still limited. Unfortunately, for some patients, the ﬁnancial contribu-
tion for a doctor's visit was a reason to refrain from follow-up. Another
interesting ﬁnding was that 65% of the included patients were female,
in contrast to the 50% female patients in the CONCOR registry.
Apparently, the campaignhas attractedmore attention amongwomen.
In conclusion, we were able to register a considerable amount of
‘'missing” adults and the success of our campaign is a great stimulus to
continue our efforts to increase awareness in the general population
and retrieve those patients who are lost to follow-up. Furthermore our
study can serve as a model for other countries to start similar programs.
In 2008, the Netherlands Society of Cardiology organized a
sponsored bicycle ride from Amsterdam (the Netherlands) to the
conference of the European Society of Cardiology in Munich
(Germany). The raised 32,000 Euro was aimed for CONCOR as an
unrestricted grant to realize the campaign.
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Table 1
Congenital heart defects (n=593).
Mild congenital heart defects, n (%) 504 (85%)
Atrial septal defect 182
Ventricular septal defect 176
Patent arterial duct 87
Pulmonary valvar stenosis 32
Other mild defects 27
Moderate congenital heart defects, n (%) 83 (14%)
Aortic coarctation 46
Tetralogy of Fallot 13
Atrioventricular septal defect 11
Partially anomalous pulmonary venous connections 6
Sinus venosus atrial septal defect 5
Other moderate defects 2
Severe congenital heart defects, n (%) 6 (1%)
Complete transposition of the great arteriesa 4
Congenitally corrected transposition of the great arteries 1
Double chambered right ventricle 1
Numbers present total of new ﬁndings.
a 2 Senning procedure, 1 arterial switch operation, 1 unknown.
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